Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer

Last updated: March 13, 2025
Sponsor: Rutgers, The State University of New Jersey
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Cervical Cancer

Uterine Fibroids

Vaginal Cancer

Treatment

Informational intervention

survey administration

Clinical Study ID

NCT05220033
Pro2019002089
131908
  • Ages > 18
  • Female

Study Summary

This study looks at how well the Journey Ahead intervention works in improving coping and communication skills in participants with gynecologic cancers.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed with any stage of primary ovarian cancer, primary peritoneal cancer, orprimary fallopian tube cancer or experienced a recurrence in the past 5 years;

  • Diagnosed with High Grade Stage 2, any grade Stage 3 or higher endometrial cancer orexperienced a recurrence in the past 5 years;

  • Diagnosed with Stage 2 or higher cervical cancer or experienced a recurrence withinthe past 5 years;

  • Diagnosed with any stage Uterine Cancer (both Sarcoma and carcinosarcoma) orexperienced a recurrence in the past 5 years;

  • At the time of recruitment the patient has received chemotherapy or radiation in thepast 5 years, or is less than 5 years post-cancer surgery;

  • At the time of recruitment, a Karnofsky Performance Status of 80 or above or anEastern Cooperative Oncology Group (ECOG) (80) score of 0 or 1;

  • 18 years of age or older;

  • English speaking;

  • Has internet access, able to view the online intervention sessions and attendtelephone or video/telehealth chats to discuss the session content and providefeedback;

  • Must give informed consent within 5 years of diagnosis.

Exclusion

Exclusion Criteria:

Study Design

Total Participants: 30
Treatment Group(s): 2
Primary Treatment: Informational intervention
Phase:
Study Start date:
July 14, 2020
Estimated Completion Date:
December 01, 2025

Study Description

Primary goals of this project are:

Objective 1: Phase 1: To collect feedback from patients on CCI online and to assess patient's evaluation of CCI online.

Objective 2: Phase 1: To examine the feasibility and acceptability of a CCI online.

Objective 3: Phase 1/2: To collect preliminary data on changes in distress and coping associated with participation in CCI online.

Connect with a study center

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey 08901
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.